.png){kind=icon}
Y
Yi-Wei Tang
H指数:76
被引数:2.4万
个人简介
Dr. Yi-Wei Tang obtained his medical training from Fudan University Shanghai School of Medicine and a Ph.D. in microbiology and immunology from Vanderbilt University. Dr. Tang is currently a Professor and Academic Dean of the College of Public Health at Chongqing Medical University, a member of the Academy Global Strategy Working Group at the American Academy of Microbiology, an Associate Editor for the Emerging Microbes and Infection, and a co-editor-in-chief for the iLABMED. He was a Lecturer and Clinical Fellow at the Mayo Clinic, a Professor at the Vanderbilt University School of Medicine, the Chief of the Clinical Microbiology Service at the Memorial Sloan-Kettering Cancer Center, a Professor of Pathology and Laboratory Medicine at the Weill Medical College of Cornell University, and the China Chief Medical Officer of Danaher Corporation/Cepheid. He was also the Chairman of the Overseas Chinese Society for Microbiology, a member of the Medical Devices Advisory Committee of the US Food and Drug Administration, and a curator of the American Society for Microbiology Registry on COVID-19. Dr. Tang ranks among the top of the scientific field in clinical and molecular microbiology, as evidenced by his election as an Editor for the Journal of Clinical Microbiology, an Associate Editor for the Journal of Molecular Diagnostics, a Fellow of the American Academy for Microbiology and of the Infectious Disease Society of America. Dr. Tang has been recognized for his extraordinary expertise in molecular microbiology diagnosis and monitoring with over 250 peer-reviewed articles and over 150 book chapters in this field during the past 25 years (Google Scholar h-index 85, i10-index 318).
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
- Editor for the Journal of Clinical Microbiology｜Journal of Clinical Microbiology
- Associate Editor for the Journal of Molecular Diagnostics｜Journal of Molecular Diagnostics
- Fellow of the American Academy for Microbiology｜American Academy for Microbiology
机器学习赋能的污水基监测用于新兴病原体检测和监测：当前应用、挑战及未来展望
微生物感染实验室诊断技术的螺旋式发展
关于游轮上近期汉坦病毒爆发的错误信息
耐碳青霉烯肺炎克雷伯菌NDM-21基因携带株在新生儿重症监护病房中的新发感染及医院内传播
Virulence
IF5.4
使用SB525334阻断TGF-β可增强B7-H3 CAR-γδT细胞对胶质母细胞瘤的疗效
李斯特菌温和噬菌体与致病性噬菌体的基因组组成和密码子使用的对比
Xpert Carba-R联合LAMP在诊断和预测碳青霉烯耐药革兰阴性杆菌肺炎中的应用价值
即时按需流感和呼吸道合胞病毒检测对急性呼吸道疾病儿科门诊患者抗生素处方和临床结局的影响: 一项前瞻性、半随机、对照研究
基于Xpert® Carba-R的碳青霉烯耐药菌筛查对造血干细胞移植受者感染相关死亡率的影响
Xpert Carba-R检测试剂盒直接检测住院患者呼吸道标本中碳青霉烯酶基因的分析性能：一项中国多中心评估研究
抗体Fc糖基化的定量靶向分析方法（Glyco-MRM）
习惯性咖啡摄入、遗传易感性与非传染性慢性疾病多重患病轨迹：一项来自英国生物银行的前瞻性研究
中国流行多样化HIV-1亚型的Xpert HIV Qual XC检测试剂的临床评估
靶向病灶巨噬细胞的纳米药物调节胆固醇稳态以治疗动脉粥样硬化
Advanced Materials
IF26.8
基于光纤的下一代可穿戴/植入式传感器及其应用：从体外到体内
ACS Sensors
IF9.1
单核细胞分布宽度（MDW）作为HIV感染者中脓毒症的可信赖诊断生物标志物
基于树突状脂肽的经皮siRNA递送系统，用于银屑病的有效非侵入性治疗
